Skip to content

Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.

Eficàcia i Seguretat de la descompressió orbitària en Orbitopatia distiroïdal Utilitzant Models Individualitzats d'impressió 3D Per la planificació i simulació de la Cirurgia.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04662190
Enrollment
12
Registered
2020-12-10
Start date
2021-07-05
Completion date
2026-06-30
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified

Brief summary

This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.

Interventions

DEVICE3D printing model/guide.

Orbital decompression surgery will be previously planned and simulated using 3D-printed individualized models. In the operating room, surgery will be assisted with 3D-printed individualized guides.

Orbital decompression surgery will be previously planned and simulated using the actual standard methods.

Sponsors

Societat Catalana d'Oftalmologia
CollaboratorUNKNOWN
Althaia Xarxa Assistencial Universitària de Manresa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification). * Volunteers older than 18 years old. * Ability to read. * Acceptation to participate and signature of informed consent.

Exclusion criteria

* Younger than 18 years old. * Previous orbital surgery. * Any coexisting disease preventing follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative complications6 monthsIntraoperative complications
Postoperative complications6 monthsPostoperative complications
Exophthalmos6 monthsExophthalmos measured in millimeters
Diplopia6 monthsDiplopia correction

Countries

Spain

Contacts

Primary ContactEduard Pedemonte-Sarrias, MD, PhD
epedemonte@althaia.cat+34678091233
Backup ContactAnna Arnau, PhD
aarnau@althaia.cat

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026